Loading...
•
Dec 28, 2024
Masimo Q4 2024 Earnings Report
Masimo experienced revenue growth driven by healthcare segment performance.
Key Takeaways
Masimo reported a net loss of $349.6 million for Q4 2024 due to impairment charges related to Sound United. Revenue for the quarter increased by 9% year-over-year, driven by strong healthcare segment performance. Non-GAAP net income per diluted share grew by 44% compared to the prior year period.
Consolidated revenue grew 9% year-over-year to $601 million.
GAAP net loss of $349.6 million, driven by impairment charges.
Healthcare revenue grew 8% year-over-year to $368 million.
Non-GAAP net income per diluted share was $1.80, a 44% increase.
Masimo
Masimo
Forward Guidance
Masimo expects revenue growth and increased earnings for 2025, driven by strategic realignment and a focus on healthcare.
Positive Outlook
- Healthcare revenue expected to grow by 8% to 11% in 2025.
- Increased focus on healthcare business following strategic realignment.
- Non-GAAP earnings per share expected to increase to between $5.10 and $5.40.
- Strong momentum in customer contracts.
- One additional calendar week for healthcare business revenue in 2025.
Challenges Ahead
- Potential impact from new tariffs on products sourced from Mexico.
- No revenue guidance provided for the non-healthcare segment.
- Ongoing litigation-related expenses.
- Potential impact from fluctuations in foreign currency exchange rates.
- Cost pressures on healthcare product lines.